Nutraceutical Actives: How Solubility and Stability Decide the Dosage Form You Buy

Two suppliers quote the same "98% by HPLC" lutein. One dissolves cleanly into a gummy premix and still looks right after twelve months on the shelf; the other throws sediment in a clear beverage and loses a third of its colour in six weeks. The assay was never the difference - the delivery form was. For a nutraceutical active, water solubility and oxidative stability are the two axes that decide which commercial form you can actually buy: oil solution, oil suspension, beadlet, or microencapsulated water-dispersible powder.

This guide covers nine actives we ship in bulk - lutein, curcumin, ubiquinol, silybin, rutin, hydroxytyrosol, spermidine, dihydroberberine and paraxanthine - and turns each one into a purchasing decision rather than a label claim.

Start with the two axes, not the dosage

The marketing conversation starts with milligrams per serving. The technical conversation should start with two questions instead: does the molecule dissolve in water or in oil, and what destroys it - light, oxygen, heat, moisture or pH? The answers narrow the candidate forms immediately.

Read that table as three groups, because each group shares a manufacturing logic.

Group 1 - crystalline, oil-soluble, oxidation-prone: lutein, ubiquinol, curcumin

• Lutein (127-40-2). A xanthophyll carotenoid from marigold, insoluble in water and soluble in oils, with a melting point of 190-195 °C for the pure substance. The commercial answer is dispersion, not dissolution: beadlets at 5%, 10% and 20% for tablets, capsules and gummies; cold-water-soluble (CWS) and cold-water-dispersible (CWD) powders at 5-20% for beverages and sachets; and oil grades at 20-90% for softgels. EFSA has set an acceptable daily intake of 1 mg/kg body weight, and lutein is authorised as food colour E161b. Practical use levels run 10-20 mg per day in supplements and 0.01-0.1% in beverages - a two-order-of-magnitude span that makes the grade, not the dose, the first specification to fix.
• Ubiquinol (992-78-9). The reduced, active form of coenzyme Q10, melting at only 48-49 °C against 51-52 °C for ubiquinone, with a log P above 10. It dissolves in lipids at roughly 15 mg/mL in MCT oil and is practically insoluble in water. Because the molecule is a hydroquinone, moisture is the enemy: water catalyses conversion back to oxidised ubiquinone, which is why loss on drying is normally capped at 0.2%, total impurities at 1.0% and any single related substance at 0.5%. Blending rooms are held below 22 °C, because friction heat in a high-shear mixer will melt the crystals and cause agglomeration. Typical servings are 50-200 mg, and microencapsulated CWS grades exist for beverages where an oil form cannot be used.
• Curcumin (458-37-7). The reference example of a solubility-limited active: water solubility of about 11 ng/mL and oral bioavailability in the region of 1%. It is also pH-sensitive, degrading under alkaline conditions, and it is polymorphic - the stable form melts at 183-184 °C, while a metastable form at 174 °C dissolves two to three times faster. The commercially meaningful options are therefore complexes and solid dispersions rather than the raw powder: a hydroxypropyl-β-cyclodextrin solid dispersion has been reported to raise solubility by roughly 299-fold by grinding and up to 489-fold by solvent evaporation, while a curcumin-L-carnitine cocrystal gave about 6.3 times the AUC and 10.7 times the Cmax of pure curcumin in rats. If you buy 95% curcuminoid powder, buy it knowing that the buyer, not the powder, owns the absorption step.

Group 2 - bioavailability is the constraint: silybin, dihydroberberine, rutin

These actives fail twice over. Solubility is low and permeability or metabolic stability is limited, so the fix is a carrier or a prodrug, not a finer powder.

• Silybin (22888-70-6). The main active flavonolignan of milk thistle, and a Biopharmaceutics Classification System Class IV substance: water solubility below 50 µg/mL and low permeability. Absolute oral bioavailability of the pure compound is around 1%, and 20-50% of an oral silymarin dose is absorbed at best, with over 80% of circulating material present as glucuronide and sulfate conjugates. Two specifications matter commercially. First, silymarin is standardised at 70-80% total flavonolignans, of which silybin A and B are only 50-60% - so a "1000 mg milk thistle" label can carry 400 mg or 700 mg of silybin, and the two are not interchangeable. Second, the phospholipid complex changes the economics: complexing silybin with phosphatidylcholine at roughly 1:1 to 1:2 gives peak plasma levels four to ten times higher than a conventional dry extract, with a reported Cmax of 207 µg/L against 12.6 µg/L for an equivalent silymarin tablet.
• Dihydroberberine (483-15-8). The reduced form of berberine, supplied as a prodrug rather than as a different active: it is absorbed as dihydroberberine and oxidised back to berberine in the body. The chemistry is simple - the charged quaternary nitrogen of berberine becomes a tertiary amine, the molecule turns lipophilic, and it stops being a good substrate for P-glycoprotein efflux. The numbers are large. Standard berberine HCl has oral bioavailability below 1%, which is why protocols run 1000-3000 mg per day; a 2021 randomised crossover study in healthy men found that 100 mg of dihydroberberine produced several-fold higher plasma berberine exposure than 500 mg of berberine HCl, and animal work reports 4.8 times the AUC. Effective dihydroberberine doses are therefore 100-200 mg rather than 1000-1500 mg. Two formulation constraints follow. The molecule is sensitive to light and oxygen and tends to agglomerate and build static on handling, which is why high-density granulated grades (bulk density above 0.6 g/mL) exist for capsule filling. And because stomach acid converts dihydroberberine back to berberine before it reaches the small intestine, enteric protection is not a nice-to-have - it is the mechanism. A plain two-piece capsule deletes most of the benefit you paid for.
• Rutin (153-18-4). Quercetin 3-O-rutinoside, the flavonol glycoside once called vitamin P. It is sparingly soluble in cold water, commonly quoted around 0.1 g/L, and dissolves better in hot water, which is why it appears in hot-filled beverages rather than clear cold drinks. Absorption depends on the sugar: the rutinoside has to be hydrolysed by gut microbiota to quercetin before meaningful uptake occurs, so glycoside and aglycone are not dose-equivalent either. Where a water-soluble flavonoid is essential, the semi-synthetic troxerutin is the conventional answer.

Group 3 - soluble, but constrained by oxidation or by regulation: hydroxytyrosol, spermidine, paraxanthine

Solubility is not the problem here. The constraints are oxidative degradation and, for two of the three, the regulatory status of the exact form on the market.

• Hydroxytyrosol (10597-60-1). A small ortho-diphenol from olive, freely water-soluble and well absorbed, but extensively conjugated in the enterocyte and the liver, so circulating free hydroxytyrosol is low and short-lived. It is also one of the few nutraceutical actives with an authorised European health claim: olive oil polyphenols providing at least 5 mg of hydroxytyrosol and its derivatives per day contribute to the protection of blood lipids from oxidative stress. The substance itself was authorised as a novel food ingredient, with permitted addition levels of 0.215 g/kg in fish and vegetable oils and 0.175 g/kg in spreadable fats. Because the catechol ring is both the antioxidant and the weak point, protection from oxidation during storage matters as much as the dose on the label.
• Spermidine (124-20-9). A polyamine, freely soluble in water and hygroscopic in the solid state. The regulatory position is narrower than the market suggests: the only spermidine ingredient authorised as a novel food in the EU is spermidine-rich wheat germ extract from Triticum aestivum, specified at 0.8-2.4 mg/g spermidine with a maximum daily intake of 6 mg for adults and excluding pregnant and breastfeeding women. Synthetic spermidine and its trihydrochloride salt are not authorised food ingredients in the EU, and there is no approved EU health claim. If you are buying for the European market, the specification to write is "wheat-germ extract, spermidine content x mg/g" - not "spermidine 98%".
• Paraxanthine (611-59-6). 1,7-dimethylxanthine, the primary human metabolite of caffeine, freely soluble in water and dosed at 100-300 mg per serving in energy and nootropic formulas. Its differentiation claim is metabolic rather than physical: supplying it directly bypasses CYP1A2-dependent conversion of caffeine, which varies widely between individuals. The procurement issue is status. In the EU, synthetic paraxanthine is a novel food under Regulation (EU) 2015/2283; an application (reference NF-2022-9030) has been filed, but authorisation is not yet in place, so it cannot currently be marketed as a food ingredient in Europe. In the United States it is sold as a dietary supplement ingredient under DSHEA rather than as GRAS. Confirm the destination market before you book production.

Matching the form to the application

Once the active and the market are fixed, the application picks the grade. The table below is the decision we work through with customers most often.

What to put in the purchase specification

• Assay and the method behind it - HPLC against a stated standard, not a bare percentage.
• Related substances as two limits, total and single maximum. Ubiquinol is the clearest case: 1.0% total, 0.5% single, because the degradant is the oxidised form you are trying not to ship.
• Moisture or loss on drying, stated separately from assay. For oxidation-prone crystals this single number predicts shelf life better than purity does.
• Particle size (D90) and bulk density, especially for direct compression and capsule filling.
• Carrier identity and allergen status - starch, gelatin or lecithin, with the botanical source named.
• Heavy metals, microbiology and residual solvents to the destination market's pharmacopoeia.
• Packaging and storage: nitrogen-flushed, vacuum-sealed foil or fibre drum, desiccant where the material is hygroscopic, and a stated temperature range in the unopened pack.

For the encapsulation side of the same problem - how a hydrocolloid wall is built around an oil phase - see our guide to alginates and chitosan ionic gelation. If your specification work is really about label arithmetic, the glucosamine salt forms guide follows the same logic for salt-based ingredients.

Sourcing these actives

We supply all nine actives discussed here in bulk, with CoA, TDS and SDS, and in the delivery form matched to your application rather than as a single generic grade:

• Lutein (127-40-2) - beadlet, CWS/CWD and oil grades
• Curcumin (458-37-7) - 95% curcuminoids
• Ubiquinol, reduced CoQ10 (992-78-9) - crystal, oil suspension and CWS
• Silybin (22888-70-6) and milk thistle extract
• Dihydroberberine (483-15-8) - granulated, 98%
• Rutin (153-18-4)
• Hydroxytyrosol (10597-60-1)
• Spermidine (124-20-9) and wheat-germ extract
• Paraxanthine (611-59-6)

Tell us the finished format, the destination market and the active dose per serving, and we will quote the grade, the carrier and the documentation package that go with it. Samples of 1 kg are available for bench work.